In contrast, they reported elevated levels of a number of proteins (e.g., hemopexin, histidine-rich glycoprotein, and vitronectin) that were identified in our study but did not meet our criteria for overexpression in ovarian cancer serum. This evidence concerns the gene HRG and ovarian carcinoma.